[1]
|
Grand, S., Passaro, G., Ziegler, A. et al. (1999) Necrotic tumor versus brain abscess: Importance of amino acids detected at 1H MR spectroscopy initial results. Radiology, 213, 785-793.
|
[2]
|
Lai, P.H., Ho, J.T., Chen, W.L. et al. (2002) Brain abscess and necrotic brain tumor: Discrimination with proton MR spectroscopy and diffusion-weighted imaging. American Journal of Neuroradiology, 23, 1369-1377.
|
[3]
|
Poptani, H., Gupta, R.K., Roy, R., Pandey, R., Jain, V.K. and Chhabra, D.K. (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. American Journal of Neuroradiology, 16, 1593-1603.
|
[4]
|
Lai, P.-H., Hsu, S.-S., Ding, S.-W., Ko, C.-W. Fu, J.-H. Weng, M.-J., Yeh, L.-R., Wu, M.-T., Liang, H.-L., Chen, C.-K. and Pan, H.-B. (2007) Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surgical Neurology, 68, S25- S36.
|
[5]
|
De Edelenyi, F.S., Rubin, C., Esteve, F., et al. (2000) A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: Nosologic images. Nature Medicine, 6, 1287-1289. doi:10.1038/81401
|
[6]
|
Galanaud, D., Chinot, O., Metellus, P. and Cozzone, P. (2005) Apports de la spectroscopie par résonance mag- nétique dans l’exploration des gliomes. Bulletion of Can- cer, 92, 327-331.
|
[7]
|
Vion-Dury, J., Salvan, A.-M. and Cozzone, P.J. (1999) La spectrométrie de résonance magnétique du proton dans l’exploration non invasive du métabolisme cérébral humain: Applications cliniques actuelles et futures. Re- vista de Neurología, 155, 903-926.
|
[8]
|
Galanaud, D., Nicoli, F., Figarella-Branger, D., Roche, P., Confort-Gouny, S., Le Fur, Y. and Cozzone, P.J. (2006) Spectroscopie par résonance magnétique des tumeurs cérébrales. Journal de Radiologie, 87, 822-832.
doi:10.1016/S0221-0363(06)74090-2
|
[9]
|
Galanaud, D., Chinot, O., Nicoli, F., et al. (2003) Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. Journal of Neurosurgery, 98, 269-276.
doi:10.3171/jns.2003.98.2.0269
|
[10]
|
Herminghaus, S., Dierks, T., Pilatus, U., et al. (2003) Determination of histopathological tumor grade in neuro- epithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. Journal of Neurosurgery, 98, 74-81. doi:10.3171/jns.2003.98.1.0074
|
[11]
|
Moller-Hartmann, W., Herminghaus, S., Krings, T., et al. (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology, 44, 371-381.
doi:10.1007/s00234-001-0760-0
|
[12]
|
Galanaud, D., Nicoli, F., Confort-Gouny, S., Le Fur, Y., Ranjeva, J.P., Viola, A., Girard, N. and Cozzone, P.J. (2007) Spectroscopie par résonance magnétique du pro- ton. Quelles indications neurologiques en 2007? Revue Neurologique, 163, 287-303.
doi:10.1016/S0035-3787(07)90402-6
|
[13]
|
Kimura, T., Sako, K., Gotoh, T., Tanaka, K. and Tanaka, T. (2001) In vivo single voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR in Biomedicine, 14, 339-349. doi:10.1002/nbm.711
|
[14]
|
Kimura, T., Sako, K., Tanaka, K., et al. (2004) Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201 TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. Journal of Neurosurgery, 100, 835-841.
doi:10.3171/jns.2004.100.5.0835
|
[15]
|
Yoshino, E., Ohmori, Y., Imahori, Y., et al. (1996) Irradiation effects on the metabolism of metastatic brain tumors: Analysis by positron emission tomography and 1H- magnetic resonance spectroscopy. Stereotactic and Fun- ctional Neurosurgery, 66, 240-259.
doi:10.1159/000099816
|
[16]
|
Galanaud, D., Nicoli, F., Confort-Gouny, S., Le Fur, Y., Dormont, D., Girard, N., Ranjeva, J.P. and Cozzone, P.J. (2007) Spectroscopie par résonance magnétique cérébrale Journal de Radiologie, 88, 483-496.
doi:10.1016/S0221-0363(07)89848-9
|
[17]
|
Pirzkall, A. (2004) MR-Spectroscopy: Potential for brain tumor diagnosis and guiding therapy. In: Black, P. and Loeffler, J.S., Eds., Cancer of the Nervous System, Lippincott Williams &Wilkins, Philadelphia.
|
[18]
|
Pirzkall, A., Li, X., Oh, J., Chang, S., Berger, M.S., Larson, D.A., et al. (2004) 3D MRSI for resected highgrade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI. International Journal of Radiation Oncology & Biology &* Physics, 59, 126- 137. doi:10.1016/j.ijrobp.2003.08.023
|
[19]
|
Graves, E.E., Nelson, S.J., Vigneron, D.B., Chin, C., Verhey, L., McDermott, M., et al. (2000)A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gammaknife radiosurgery of recurrent malignant gliomas. Neurosurgery, 46, 319- 326. doi:10.1097/00006123-200002000-00011
|
[20]
|
Ross, B. and Bluml, S. (2001) Magnetic resonance speccopy of the human brain. The Anatomical Record, 265, 54-84. doi:10.1002/ar.1058
|
[21]
|
De Bazelaire, C. and Lewin, M. (2005) Points forts en oncologie au RSNA 2004. Journal de Radiologie, 86, 74- 84. doi:10.1016/S0221-0363(05)81462-3
|
[22]
|
Castilo, M., Kwock, L. and Mukherji, S.K. (1996) Clinical applications of proton MR spectroscopy. American Journal of Neuroradiology, 17, 1-15.
|
[23]
|
Soaresa, D.P. and Law, M. (2009) Magnetic resonance spectroscopy of the brain: Review of metabolites and cli- nical applications. Clinical Radiology, 64, 12-21.
doi:10.1016/j.crad.2008.07.002
|
[24]
|
Grand, S., Ternier, J., Rousseau, N., Ashraf, A., Tropres, I., Remy, C. and Le Bas, J.F. (2004) Abcès cérébral: Aspects caraterisatiques en imagerie morphologique et fonctionnelle. Journal of Neuroradiology, 31, 145-147.
doi:10.1016/S0150-9861(04)96982-9
|
[25]
|
Leuthardt, E.C., Wippold, F.J., Oswood, M.C., Rich, K.M. (2002) Diffusion-weighted MR imaging in the pre-opera- tive assessment of brain abscesses. Surgical Neurology, 58, 395-402. doi:10.1016/S0090-3019(02)00929-1
|
[26]
|
Lai, P.H., Ho, J.T., Chen, W.L., Hsu, S.S., Wang, J.S., Pan, H.B., et al. (2002) Brain abscess and necrotic brain tumor: Discrimination with proton MR spectroscopy and diffusion-weighted imaging. American Journal of Neuroradiology, 23, 1369-1377.
|
[27]
|
Ebisu, T., Tanaka, C., Umeda, M., Kitamura, M., Naruse, S., Higuchi, T., et al. (1996) Discrimination of brain abscess from necrotic of cystic tumor by diffusion-weighted echo planar imaging. Magnetic Resonance Imaging, 14, 1113-1116. doi:10.1016/S0730-725X(96)00237-8
|
[28]
|
Schimitzu, H., Kumabe, T., Shirane, R. and, Yoshimoto, T. (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. American Journal of Neuroradiology, 21, 659- 665.
|
[29]
|
Castillo, M., Smith, J.K. and Kwock, L. (2000) Correlation of myo-inositol levels and grading of cerebral astrocytomes. American Journal of Neuroradiology, 2, 1645-1649.
|
[30]
|
Saraf-Lavi, E., Bowen, B.C., Pattany, P.M., et al. (2003) Proton MR Spectroscopy of gliomatosis cerebri: Case re- port of elevated myoinositol with normal choline levels. American Journal of Neuroradiology, 24, 946-951.
|
[31]
|
Guillevin, R., Menuel, C., Duffau, H., et al. (2008) Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. Journal of Neuro- Oncology, 87, 181-187. doi:10.1007/s11060-007-9508-y
|
[32]
|
Grand, S., Tropres, I., Hoffmann, D., Ziegler, A. and Le Bas, J.F. (2005) Apport de la spectroscopie 1H au diag- nostic des processus tumoraux intra-parenchymateux cé- rébraux et leur suivi thérapeutique. Neurochirurgie, 51, 299-308. doi:10.1016/S0028-3770(05)83491-5
|
[33]
|
Martin-Duverneuil, N., Guillevin, R. and Chiras, J. (2008) Imaging of gliomas. Cancer/Radiothérapie, 12, 669-675.
doi:10.1016/j.canrad.2008.07.017
|
[34]
|
Taillibert, S., Guillevin, R., Menuel, C., Sanson, M., Hoang-Xuan, K., Chiras, J. and Duffau, H. (2008) Brain lymphoma: Usefulness of the magnetic resonance spec- troscopy. Journal of Neuro-Oncology, 86, 225-229.
doi:10.1007/s11060-007-9468-2
|
[35]
|
Law, M., Cha, S., Knopp, E.A., Johnson, G., Arnett, J. and Litt, A.W. (2002) High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology, 222, 715-721.
doi:10.1148/radiol.2223010558
|
[36]
|
Pierot, L. (2005) RSNA 2004: Neuroradiologie. Journal de Radiologie, 86, 868-873.
doi:10.1016/S0221-0363(05)81461-1
|
[37]
|
Nelson, S.J., Graves, E., Pirzkall, A. et al. (2002) In vivo molecular imaging for planning radiation therapy of glio-mas: An application of 1H MRSI. Journal of Magnetic Resonance Imaging, 16, 464-476. doi:10.1002/jmri.10183
|
[38]
|
Laprie, A. (2009) Apport de l’imagerie de spectroscopie de résonance magnétique du proton et des autres imageries métaboliques à la définition des volumes cibles de radiothérapie des tumeurs gliales de l’adulte et de l’enfant. Cancer/Radiothérapie, 13, 556-561.
doi:10.1016/j.canrad.2009.07.003
|
[39]
|
Kimura, T., Sako, K., Gotoh, T., et al. (2001) In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR in Biomedicine, 14, 339-349. doi:10.1002/nbm.711
|
[40]
|
Park, I., Tamai, G., Lee, M.C., Chuang, C.F., Chang, S.M., Berger, M.S., et al. (2007) Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapymagnetic resonance spectroscopic findings. International Journal of Radiation Oncology&Biology&Physics, 69, 381-389.
doi:10.1016/j.ijrobp.2007.03.019
|